Exposure to opioid maintenance treatment reduces long-term mortality

Addiction

Volumn 103, Issue 3, 2008, Pages 462-468

  Gibson, Amy ^a   Degenhardt, Louisa ^a   Mattick, Richard P ^a   Ali, Robert ^b   White, Jason ^c   O'Brien, Susannah ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Drug & Alcohol Services South Australia   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Buprenorphine; Longitudinal; Maintenance treatment; Methadone; Mortality; Opioid dependence; RCT

Indexed keywords

BUPRENORPHINE; DIAMORPHINE; METHADONE; OPIATE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; ASPHYXIA; BIRTH; BUPRENORPHINE MAINTENANCE THERAPY; CAUSE OF DEATH; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE BLIND PROCEDURE; DRUG DEPENDENCE TREATMENT; DRUG OVERDOSE; ENDOCARDITIS; FEMALE; FOLLOW UP; GUNSHOT INJURY; HANGING; HEPATIC ENCEPHALOPATHY; HEROIN DEPENDENCE; HUMAN; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MARRIAGE; METHADONE TREATMENT; MORTALITY; NEOPLASM; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REGISTRATION; RISK ASSESSMENT; RISK REDUCTION; SURVIVAL;

ADOLESCENT; ADULT; AUSTRALIA; BUPRENORPHINE; CAUSE OF DEATH; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METHADONE; MIDDLE AGED; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 38849133402     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2007.02090.x     Document Type: Article

References (31)

1. English D. R., Holman C. D. J., Milne E., Winter M. G., Hulse G. K., Codde J. P. et al. The Quantification of Drug Caused Morbidity and Mortality in Australia. Canberra : Commonwealth Department of Human Services and Health 1995.
2. Hulse G. K., English D. R., Milne E., Holman C. D. J. The quantification of mortality resulting from the regular use of illicit opiates. Addiction 1999 94 : 221 9.
3. Gronbladh L., Ohlund L. S., Gunne L. M. Mortality in heroin addiction: impact of methadone treatment. Acta Psychiatr Scand 1990 82 : 223 7.
4. Caplehorn J. R. M., Drummer O. H. Mortality associated with New South Wales methadone programs in 1994. lives lost and saved. Med J Aust 1999 170 : 104 9.
5. Oppenheimer E., Tobutt C., Taylor C., Andrew T. Death and survival in a cohort of heroin addicts from London clinics: a 22-year follow-up study. Addiction 1994 89 : 1299 308.
6. Frischer M., Goldberg D., Rahman M., Berney L. Mortality and survival among a cohort of drug injectors in Glasgow, 1982-1994. Addiction 1997 92 : 419 27.
7. Quan V. M., Vongchak T., Jittiwutikarn J., Kawichai S., Srirak N., Wiboonnatakul K. et al. Predictors of mortality among injecting and non-injecting HIV-negative drug users in northern Thailand. Addiction 2007 102 : 441 6.
8. O'Driscoll P. T., McGough J., Hagan H., Thiede H., Critchlow C., Alexander E. R. Predictors of accidental fatal drug overdose among a cohort of injection drug users. Am J Public Health 2001 91 : 984 7.
9. Walsh S. L., Preston K. L., Stitzer M. L., Cone E. J., Bigelow G. E. Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin Pharmacol Ther 1994 55 : 569 80.
10. Auriacombe M., Franques P., Tignol J. Deaths attributable to methadone versus buprenorphine France. JAMA 2001 285 : 3.
11. Gibson A., Degenhardt L. Mortality Related to Naltrexone in the Treatment of Opioid Dependence: A Comparative Analysis. Sydney : National Drug and Alcohol Research Centre 2005.
12. Gibson A., Degenhardt L. Mortality related to pharmacotherapies for opioid dependence: a comparative analysis of coronial records. Drug Alcohol Rev 2007 26 : 405 10.
13. Mattick R. P., Ali R., White J. M., O'Brien S., Wolk S., Danz C. Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients. Addiction 2003 98 : 441 52.
14. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn, edited text revision. Washington, DC : American Psychiatric Association 2000.
15. Darke S., Hall W., Wodak A., Heather N., Ward J. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index. Br J Addict 1992 87 : 733 42.
16. Gossop M., Darke S., Griffiths P., Hando J., Powis B., Hall W. et al. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995 90 : 607 14.
17. Caplehorn J. R. M. Deaths in the first two weeks of maintenance treatment in NSW in 1994: identifying cases of iatrogenic methadone toxicity. Drug Alcohol Rev 1998 17 : 9 17.
18. Lintzeris N., Clark N., Winstock A., Dunlop A., Muhleisen P., Gowing L. et al. National Clinical Guidelines and Procedures for the Use of Buprenorphine in the Treatment of Heroin Dependence. Canberra : Australian Government Department of Health and Ageing 2006.
19. Lintzeris N., Bell J., Bammer G., Jolley D. J., Rushworth L. A randomized controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawal. Addiction 2002 97 : 1395 404.
20. Gibson A. E., Doran C. M., Bell J. R., Ryan A., Lintzeris N. A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial. Med J Aust 2003 179 : 38 42.
21. Lintzeris N., Ritter A., Panjari M., Clark N., Kutin J., Bammer G. Implementing buprenorphine treatment in community settings in Australia: experiences from the Buprenorphine Implementation Trial. Am J Addict 2004 13 : S29 S41.
22. Caplehorn J. R. M., Dalton M. S. Y. N., Cluff M. C., Petrenas A. M. Retention in methadone maintenance and heroin addicts' risk of death. Addiction 1994 89 : 203 7.
23. Zanis D. A., Woody G. E. One-year mortality rates following methadone treatment discharge. Drug Alcohol Depend 1998 52 : 257 60.
24. Esteban J., Gimeno C., Barril J., Aragones A., Climent J. M., de la Cruz Pellin M. Survival study of opioid addicts in relations to its adherance to methadone maintenance treatment. Drug Alcohol Depend 2003 70 : 193 200.
25. Brugal M. T., Domingo-Salvany A., Puig R., Barrio G., Garcia de Olalla P., de la Fuente L. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. Addiction 2005 100 : 981 9.
26. Australian Institute of Health and Welfare. Australia's Health, 2006. Canberra : Australian Institute of Health and Welfare 2006.
27. Darke S., Degenhardt L., Mattick R. Mortality Amongst Illicit Drug Users. Melbourne : Cambridge University Press 2007.
28. Degenhardt L., Hall W., Lynskey M., Warner-Smith M. Illicit drug use. In : Ezzati M., Lopez A. D., Rodgers A., Murray R., editors. Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors, chapter 13. Geneva : World Health Organization 2004, p. 1109 76.
29. Aceijas C., Stimson G. V., Hickman M., Rhodes T. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 2004 18 : 2295 303.
30. Darke S., Kaye S., Duflou J. Systemic disease among cases of fatal opioid toxicity. Addiction 2006 101 : 1299 305.
31. Wong J. B., McQuillan G. M., McHutchison J. G., Poynard T. Estimating future hepatitis C morbidity, mortality and costs in the United States. Am J Public Health 2000 90 : 1562 9.